Complete Filing Data
Journey Medical Corp reported Stockholders Equity of $31.85 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Journey Medical Corp did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Net Income * | -$11.4M | -$14.7M | -$3.9M | -$29.6M | -$44.0M | $5.3M |
| Revenue * | $61.2M | $55.1M | $59.7M | $71.0M | $63.1M | $44.5M |
| Selling General And Administrative Expense | $44.4M | $40.2M | $43.9M | $59.5M | $39.8M | $22.1M |
| Operating Income Loss | -$8.2M | -$13.7M | -$2.1M | -$27.5M | -$34.9M | $7.9M |
| Nonoperating Income Expense | -$3.2M | -$934.0K | -$1.6M | -$2.0M | -$7.5M | -$698.0K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$11.4M | -$14.6M | -$3.6M | -$29.6M | -$42.4M | $7.2M |
| Research And Development Expense | $480.0K | $9.9M | $7.5M | $10.9M | $2.7M | |
| Amortization Of Intangible Assets | $4.3M | $3.4M | $3.8M | $4.3M | $2.5M | $1.4M |
| Cost Of Revenue | $20.9M | $20.9M | $22.9M | $30.8M | $32.1M | $14.6M |
| Income Tax Expense Benefit | $60.0K | $61.0K | $221.0K | $63.0K | $1.6M | $1.9M |
| Accrued Income Taxes Current | $70.0K | $60.0K | $53.0K | $35.0K | $8.0K | |
| Interest Expense | $1.7M | $2.0M | $7.0M | $698.0K | ||
| Income Taxes Paid Net | $50.0K | $125.0K | $181.0K | $168.0K | $158.0K | $110.0K |
| Interest Expense Nonoperating | $3.7M | $2.7M | $1.7M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$2.3M | -$3.8M | -$4.1M | -$2.4M | -$3.4M | -$10.4M | $16.8M | -$8.4M | -$10.1M | -$10.1M | -$7.5M | -$1.4M | -$10.6M | -$11.9M | $268.0K | $29.0K |
| Revenue * | $17.0M | $15.0M | $13.1M | $14.6M | $14.9M | $13.0M | $15.3M | $17.0M | $12.2M | $16.0M | $18.2M | $20.8M | $19.6M | $15.3M | $10.7M | $9.4M |
| Selling General And Administrative Expense | $12.1M | $11.9M | $10.6M | $11.4M | $10.3M | $8.4M | $8.6M | $12.1M | $13.3M | $15.6M | $15.2M | $14.7M | $10.8M | $7.8M | $6.2M | $5.8M |
| Operating Income Loss | -$1.5M | -$2.9M | -$3.3M | -$2.9M | -$2.9M | -$10.1M | $17.2M | -$7.7M | -$9.6M | -$9.5M | -$7.1M | -$888.0K | -$12.6M | -$13.8M | $585.0K | $239.0K |
| Nonoperating Income Expense | -$786.0K | -$860.0K | -$749.0K | $504.0K | -$434.0K | -$352.0K | -$361.0K | -$710.0K | -$575.0K | -$578.0K | -$450.0K | -$386.0K | -$1.4M | -$1.5M | -$221.0K | -$187.0K |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$2.3M | -$3.7M | -$4.1M | -$2.4M | -$3.4M | -$10.4M | $16.9M | -$8.4M | -$10.1M | -$10.1M | -$7.6M | -$1.3M | -$14.0M | -$15.3M | $364.0K | $52.0K |
| Research And Development Expense | $287.0K | $39.0K | $842.0K | $913.0K | $7.9M | $2.2M | $1.8M | $2.0M | $2.8M | $2.6M | $1.3M | $718.0K | $29.0K | |||
| Amortization Of Intangible Assets | $1.1M | $1.1M | $1.1M | $814.0K | $814.0K | $814.0K | $1.1M | $1.0M | $1.0M | $1.0M | $700.0K | $700.0K | $584.0K | $400.0K | ||
| Cost Of Revenue | $5.3M | $6.5M | $6.8M | $6.4M | $7.8M | $6.4M | $7.2M | $7.6M | $8.2M | $11.2M | $7.5M | $3.9M | $3.4M | |||
| Income Tax Expense Benefit | $60.0K | $95.0K | $10.0K | -$64.0K | $104.0K | -$3.4M | -$3.4M | $96.0K | $23.0K | |||||||
| Accrued Income Taxes Current | $71.0K | $71.0K | $59.0K | $37.0K | $130.0K | $35.0K | $35.0K | $22.0K | $12.0K | $112.0K | ||||||
| Interest Expense | $548.0K | $268.0K | $756.0K | $650.0K | $559.0K | $454.0K | $389.0K | $1.4M | $1.3M | $221.0K | ||||||
| Income Taxes Paid Net | $7.0K | |||||||||||||||
| Interest Expense Nonoperating | $937.0K | $937.0K | $891.0K | $758.0K | $563.0K | $548.0K | $268.0K | $756.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Stockholders Equity | $31.9M | $20.1M | $20.4M | $17.0M | $42.0M | $10.3M | $2.8M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $24.1M | $20.3M | $27.4M | $32.0M | $49.1M | $8.2M | $4.8M |
| Retained Earnings Accumulated Deficit | -$98.5M | -$87.0M | -$72.4M | -$68.5M | -$38.9M | $5.1M | |
| Prepaid Expense And Other Assets Current | $3.4M | $3.2M | $3.6M | $3.3M | $2.4M | $1.7M | |
| Operating Lease Right Of Use Asset Amortization Expense | $88.0K | $91.0K | $88.0K | $88.0K | $86.0K | $91.0K | |
| Operating Lease Right Of Use Asset | $111.0K | $199.0K | $101.0K | $189.0K | $89.0K | $175.0K | |
| Operating Lease Liability Current | $101.0K | $83.0K | $99.0K | $83.0K | $98.0K | $85.0K | |
| Liabilities Current | $37.4M | $35.2M | $41.9M | $66.8M | $51.6M | $28.1M | |
| Liabilities And Stockholders Equity | $94.6M | $80.2M | $76.8M | $105.2M | $97.3M | $51.9M | |
| Liabilities | $62.7M | $60.2M | $56.5M | $88.2M | $55.2M | $41.6M | |
| Inventory Net | $9.6M | $14.4M | $10.2M | $14.2M | $9.9M | $1.4M | |
| Intangible Assets Net Excluding Goodwill | $27.6M | $31.9M | $20.3M | $27.2M | $12.6M | $15.0M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $3.8M | -$7.1M | -$4.6M | -$17.1M | $40.8M | $3.4M | |
| Cash And Cash Equivalents At Carrying Value | $24.1M | $20.3M | $27.4M | $32.0M | $49.1M | $8.2M | |
| Assets Current | $66.9M | $48.2M | $56.5M | $77.7M | $84.5M | $35.2M | |
| Assets | $94.6M | $80.2M | $76.8M | $105.2M | $97.3M | $51.9M | |
| Accrued Liabilities Current | $27.6M | $17.4M | $20.4M | $19.4M | $22.7M | $21.5M | |
| Accounts Receivable Net Current | $29.8M | $10.2M | $15.2M | $28.2M | $23.1M | $23.9M | |
| Accounts Payable Current | $8.9M | $16.1M | $18.1M | $36.6M | $22.8M | $1.8M | |
| Amortization Of Debt Discount Premium | $466.0K | $307.0K | $356.0K | $63.0K | $2.6M | $0.00 | |
| Other Assets Noncurrent | $6.0K | $95.0K | $150.0K | $6.0K | |||
| Interest Payable Current | $398.0K | $404.0K | $22.0K | $160.0K | |||
| Repayments Of Notes Payable | $625.0K | $1.3M | $1.0M | $5.0M | $5.3M | $500.0K | |
| Long Term Debt Noncurrent | $25.3M | $24.9M | $14.6M | $19.8M | |||
| Operating Lease Liability Noncurrent | $18.0K | $118.0K | $9.0K | $108.0K | $97.0K | ||
| Other Liabilities Current | $455.0K | $528.0K | $195.0K | $413.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $25.9M | $19.2M | $21.5M | $10.9M | $11.3M | $13.0M | $17.4M | $5.0K | $7.5M | $26.2M | $34.8M | $41.4M | -$11.7M | -$792.0K | $10.8M | $6.8M | $6.5M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $24.9M | $20.3M | $21.1M | $22.5M | $23.9M | $24.1M | $24.7M | $17.0M | $26.1M | $34.9M | $38.1M | $41.3M | $21.7M | $12.2M | $19.0M | $3.9M | |
| Retained Earnings Accumulated Deficit | -$97.2M | -$94.9M | -$91.1M | -$88.5M | -$86.2M | -$82.8M | -$70.2M | -$87.0M | -$78.6M | -$57.9M | -$47.8M | -$40.3M | -$17.1M | ||||
| Prepaid Expense And Other Assets Current | $1.6M | $2.5M | $2.4M | $1.2M | $2.4M | $2.6M | $924.0K | $1.8M | $2.5M | $942.0K | $1.0M | $1.6M | $1.8M | ||||
| Operating Lease Right Of Use Asset Amortization Expense | $21.0K | $22.0K | $22.0K | $22.0K | $21.0K | ||||||||||||
| Operating Lease Right Of Use Asset | $134.0K | $156.0K | $178.0K | $32.0K | $55.0K | $79.0K | $124.0K | $146.0K | $167.0K | $22.0K | $45.0K | $67.0K | $111.0K | ||||
| Operating Lease Liability Current | $98.0K | $96.0K | $93.0K | $34.0K | $59.0K | $84.0K | $97.0K | $95.0K | $93.0K | $25.0K | $49.0K | $74.0K | $96.0K | ||||
| Liabilities Current | $39.7M | $40.5M | $40.2M | $33.3M | $34.1M | $38.9M | $48.5M | $68.2M | $76.9M | $60.8M | $60.1M | $61.0M | $59.8M | ||||
| Liabilities And Stockholders Equity | $85.2M | $81.2M | $85.0M | $64.0M | $65.2M | $66.6M | $65.9M | $69.7M | $95.9M | $108.1M | $113.5M | $120.9M | $89.1M | ||||
| Liabilities | $59.3M | $61.9M | $63.4M | $53.1M | $53.9M | $53.6M | $48.5M | $69.7M | $88.4M | $82.0M | $78.7M | $79.5M | $100.8M | ||||
| Inventory Net | $11.8M | $12.9M | $12.5M | $11.8M | $9.7M | $10.6M | $11.0M | $12.2M | $13.3M | $15.2M | $16.1M | $16.1M | $11.6M | ||||
| Intangible Assets Net Excluding Goodwill | $28.7M | $29.7M | $30.8M | $17.8M | $18.7M | $19.5M | $21.1M | $21.9M | $26.1M | $28.4M | $29.4M | $30.5M | $13.0M | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $765.0K | -$3.4M | -$5.9M | -$7.8M | $10.8M | ||||||||||||
| Cash And Cash Equivalents At Carrying Value | $24.9M | $20.3M | $21.1M | $22.5M | $23.9M | $24.1M | $24.7M | $8.2M | $17.3M | $34.9M | $38.1M | $41.3M | |||||
| Assets Current | $56.4M | $51.3M | $54.0M | $46.2M | $46.5M | $47.0M | $44.7M | $47.7M | $60.7M | $79.6M | $83.9M | $90.3M | $66.8M | ||||
| Assets | $85.2M | $81.2M | $85.0M | $64.0M | $65.2M | $66.6M | $65.9M | $69.7M | $95.9M | $108.1M | $113.5M | $120.9M | $89.1M | ||||
| Accrued Liabilities Current | $21.2M | $22.6M | $23.0M | $16.0M | $16.0M | $20.0M | $16.0M | $23.3M | $17.4M | $17.8M | $19.4M | $25.9M | $26.0M | ||||
| Accounts Receivable Net Current | $18.0M | $15.6M | $18.0M | $10.7M | $10.5M | $9.8M | $8.0M | $16.7M | $27.6M | $28.5M | $28.7M | $31.2M | $31.7M | ||||
| Accounts Payable Current | $11.6M | $12.8M | $14.4M | $15.3M | $14.6M | $15.3M | $28.2M | $31.8M | $43.7M | $33.6M | $32.8M | $27.0M | $28.2M | ||||
| Amortization Of Debt Discount Premium | $101.0K | $62.0K | $17.0K | $14.0K | |||||||||||||
| Other Assets Noncurrent | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $88.0K | $103.0K | $110.0K | $118.0K | $749.0K | |||||||
| Interest Payable Current | $416.0K | $416.0K | $381.0K | $332.0K | $251.0K | $241.0K | $83.0K | $165.0K | $125.0K | $77.0K | $66.0K | ||||||
| Repayments Of Notes Payable | $625.0K | $2.0M | $1.8M | ||||||||||||||
| Long Term Debt Noncurrent | $19.5M | $21.4M | $23.1M | $19.8M | $19.7M | $14.7M | $9.9M | $19.8M | $14.8M | $14.8M | |||||||
| Operating Lease Liability Noncurrent | $44.0K | $69.0K | $94.0K | $34.0K | $59.0K | $84.0K | $24.0K | ||||||||||
| Other Liabilities Current | $755.0K | $840.0K | $399.0K | $370.0K | $260.0K | $198.0K | $1.1M | $603.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Share Based Compensation | $6.3M | $6.1M | $2.6M | $4.4M | $2.5M | $153.0K |
| Net Cash Provided By Used In Operating Activities | -$12.4M | -$9.1M | $5.2M | -$13.5M | -$2.2M | $5.1M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $164.0K | -$376.0K | $279.0K | $871.0K | $774.0K | $1.0M |
| Increase Decrease In Operating Lease Liability | -$82.0K | -$96.0K | -$83.0K | -$95.0K | -$84.0K | -$83.0K |
| Increase Decrease In Inventories | -$4.8M | $4.2M | -$4.0M | -$1.7M | $8.5M | $547.0K |
| Increase Decrease In Accrued Liabilities | $10.1M | -$2.9M | $962.0K | -$3.6M | $1.2M | $2.4M |
| Increase Decrease In Accounts Receivable | $19.3M | -$4.5M | -$12.6M | $5.4M | -$768.0K | $5.0M |
| Increase Decrease In Accounts Payable | -$7.2M | -$2.1M | -$18.4M | $14.3M | $20.4M | -$204.0K |
| Increase Decrease In Account Payable Related Party | -$73.0K | $333.0K | -$218.0K | -$228.0K | $1.9M | $52.0K |
| Net Cash Provided By Used In Financing Activities | $16.2M | $17.0M | -$4.8M | $16.5M | $53.0M | -$487.0K |
| Increase Decrease In Accrued Income Taxes Payable | $10.0K | $7.0K | $18.0K | $27.0K | -$91.0K | $2.2M |
| Proceeds From Stock Options Exercised | $350.0K | $207.0K | $121.0K | $142.0K | $7.0K | $13.0K |
| Increase Decrease In Interest Payable Net | -$6.0K | $382.0K | -$138.0K | $160.0K | ||
| Net Cash Provided By Used In Investing Activities | -$15.0M | -$5.0M | -$20.0M | -$10.0M | -$1.2M | |
| Increase Decrease In Other Operating Assets | -$6.0K | -$55.0K | $144.0K | $0.00 | ||
| Proceeds From Long Term Lines Of Credit | $10.0M | $15.0M | $19.8M | |||
| Proceeds From Issuance Of Common Stock | $16.4M | $7.9M | $4.5M | $32.5M | ||
| Payments To Acquire Productive Assets | $15.0M | $5.0M | $20.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|
| Share Based Compensation | $1.3M | $1.4M | $646.0K | $773.0K | $22.0K |
| Net Cash Provided By Used In Operating Activities | -$2.8M | -$5.0M | -$956.0K | $884.0K | $1.4M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$817.0K | -$1.0M | -$832.0K | -$830.0K | -$472.0K |
| Increase Decrease In Operating Lease Liability | -$14.0K | -$24.0K | -$14.0K | -$24.0K | -$15.0K |
| Increase Decrease In Inventories | -$1.9M | $374.0K | -$881.0K | $234.0K | $887.0K |
| Increase Decrease In Accrued Liabilities | $5.6M | -$317.0K | -$2.0M | $2.9M | -$395.0K |
| Increase Decrease In Accounts Receivable | $8.0M | -$5.4M | -$466.0K | $8.0M | -$390.0K |
| Increase Decrease In Accounts Payable | -$1.6M | -$2.8M | $7.1M | $4.7M | $566.0K |
| Increase Decrease In Account Payable Related Party | -$129.0K | $3.0K | -$43.0K | -$130.0K | $70.0K |
| Net Cash Provided By Used In Financing Activities | $3.6M | $1.6M | $52.0K | $11.4M | $9.4M |
| Increase Decrease In Accrued Income Taxes Payable | -$1.0K | -$16.0K | $104.0K | $26.0K | |
| Proceeds From Stock Options Exercised | $75.0K | $68.0K | $7.0K | ||
| Increase Decrease In Interest Payable Net | -$23.0K | $219.0K | $5.0K | $66.0K | |
| Net Cash Provided By Used In Investing Activities | -$5.0M | -$20.0M | |||
| Increase Decrease In Other Operating Assets | -$32.0K | $121.0K | |||
| Proceeds From Long Term Lines Of Credit | $14.8M | ||||
| Proceeds From Issuance Of Common Stock | $4.0M | $1.5M | |||
| Payments To Acquire Productive Assets | $5.0M | $20.0M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 24.5M | 20.4M | 18.2M | 17.5M | 10.2M | 9.1M |
| Earnings Per Share Diluted | $-0.47 | $-0.72 | $-0.21 | $-1.69 | $-4.32 | $0.49 |
| Earnings Per Share Basic | $-0.47 | $-0.72 | $-0.21 | $-1.69 | $-4.32 | $0.58 |
| Weighted Average Number Of Diluted Shares Outstanding | 24.5M | 20.4M | 18.2M | 17.5M | 10.2M | 10.8M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 25.0M | 23.3M | 22.6M | 20.5M | 20.0M | 19.8M | 18.4M | 18.0M | 17.8M | 17.6M | 17.5M | 17.3M | 9.2M | 9.2M | 9.2M | 9.1M |
| Earnings Per Share Diluted | $-0.09 | $-0.16 | $-0.18 | $-0.12 | $-0.17 | $-0.53 | $0.80 | $-0.46 | $-0.57 | $-0.57 | $-0.43 | $-0.08 | $-1.16 | $-1.30 | $0.02 | $0.00 |
| Earnings Per Share Basic | $-0.09 | $-0.16 | $-0.18 | $-0.12 | $-0.17 | $-0.53 | $0.91 | $-0.46 | $-0.57 | $-0.57 | $-0.43 | $-0.08 | $-1.16 | $-1.30 | $0.03 | $0.00 |
| Weighted Average Number Of Diluted Shares Outstanding | 25.0M | 23.3M | 22.6M | 20.5M | 20.0M | 19.8M | 21.0M | 18.0M | 17.8M | 17.6M | 17.5M | 17.3M | 9.2M | 9.2M | 10.9M | 10.8M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Costs And Expenses | $70.0M | $69.8M | $81.3M | $101.2M | $98.0M | $36.7M |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $6.3M | $6.1M | $2.6M | $4.4M | $2.5M | $153.0K |
| Interest Income | $589.0K | $757.0K | $322.0K | $60.0K | $2.0K | |
| Stock Issued During Period Value Stock Options Exercised | $207.0K | $121.0K | $142.0K | $7.0K | $13.0K | |
| Provision For Doubtful Accounts | -$211.0K | $516.0K | $435.0K | $284.0K | $48.0K | $49.0K |
| Foreign Currency Transaction Gain Loss Before Tax | -$90.0K | -$116.0K | -$183.0K | -$89.0K | ||
| Additional Paid In Capital | $130.3M | $107.1M | $92.7M | $85.5M | $80.9M | $5.2M |
| Installment Payments Licenses Net Current | $625.0K | $3.0M | $2.2M | $4.5M | $4.5M | |
| Other Income | $619.0K | $1.0M | $19.5M | $2.7M | ||
| Interest Paid Net | $3.2M | $2.0M | $1.1M | $993.0K | ||
| Paid In Kind Interest | $353.0K | $770.0K | $781.0K | $698.0K | ||
| Installment Payments Licenses Net Non Current | $0.00 | $0.00 | $1.4M | $3.6M | $8.1M | |
| Stock Issued During Period Value New Issues | $16.4M | $7.9M | $4.5M | $30.6M | ||
| Sale Of Stock Stock Issuance Costs | $507.0K | $245.0K | $140.0K | $1.92B | $1.92B | |
| Repayments Of Lines Of Credit | $30.9M | $2.9M | $6.2M | |||
| Stock Issued During Period Value Employee Stock Purchase Plan | $217.0K | $209.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Costs And Expenses | $19.2M | $17.9M | $16.5M | $17.5M | $17.8M | $23.1M | $17.3M | $24.8M | $21.8M | $25.6M | $25.4M | $24.2M | $32.3M | $29.1M | $10.1M | $9.2M |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $1.9M | $1.3M | $1.3M | $1.6M | $1.7M | $1.4M | $558.0K | $873.0K | $646.0K | $1.4M | $774.0K | $773.0K | $8.0K | $11.0K | $22.0K | $32.0K |
| Interest Income | $154.0K | $138.0K | $149.0K | $188.0K | $161.0K | $217.0K | $8.0K | $79.0K | $122.0K | $3.0K | $4.0K | $3.0K | ||||
| Stock Issued During Period Value Stock Options Exercised | $165.0K | $75.0K | $63.0K | $31.0K | $68.0K | $22.0K | $3.0K | $31.0K | $111.0K | $7.0K | ||||||
| Provision For Doubtful Accounts | $195.0K | $6.0K | $126.0K | -$76.0K | $70.0K | |||||||||||
| Foreign Currency Transaction Gain Loss Before Tax | -$3.0K | -$61.0K | -$7.0K | -$51.0K | -$32.0K | -$21.0K | -$101.0K | -$33.0K | -$47.0K | -$22.0K | ||||||
| Additional Paid In Capital | $123.1M | $114.1M | $112.6M | $99.5M | $97.5M | $95.7M | $87.6M | $87.0M | $86.1M | $84.0M | $82.6M | $81.7M | $5.4M | |||
| Installment Payments Licenses Net Current | $1.3M | $3.0M | $3.0M | $3.0M | $2.3M | $2.3M | $4.2M | $2.6M | $2.6M | $4.4M | ||||||
| Other Income | $606.0K | $19.3M | $211.0K | $48.0K | $73.0K | $56.0K | $2.5M | |||||||||
| Interest Paid Net | $813.0K | $267.0K | $535.0K | $95.0K | ||||||||||||
| Paid In Kind Interest | $98.0K | $203.0K | $221.0K | |||||||||||||
| Installment Payments Licenses Net Non Current | $1.5M | $1.5M | $1.4M | $3.8M | $3.7M | $3.5M | ||||||||||
| Stock Issued During Period Value New Issues | $6.9M | $4.0M | $194.0K | $1.5M | ||||||||||||
| Sale Of Stock Stock Issuance Costs | $187.0K | $125.0K | $6.0K | $46.0K | ||||||||||||
| Repayments Of Lines Of Credit | $27.9M | $812.0K | ||||||||||||||
| Stock Issued During Period Value Employee Stock Purchase Plan | $118.0K | $99.0K | $124.0K | $85.0K |
Most recent annual filing with the SEC: March 26, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.